Jump to ContentJump to Main Navigation
Show Summary Details

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

IMPACT FACTOR increased in 2015: 3.017
Rank 5 out of 30 in category Medical Laboratory Technology in the 2014 Thomson Reuters Journal Citation Report/Science Edition

SCImago Journal Rank (SJR) 2015: 0.873
Source Normalized Impact per Paper (SNIP) 2015: 0.982
Impact per Publication (IPP) 2015: 2.238

249,00 € / $374.00 / £187.00*

See all formats and pricing


Select Volume and Issue
Loading journal volume and issue information...

Clinical value of a competitive NT-proBNP enzyme immunoassay compared to the Roche NT-proBNP platform

Angelika Hammerer-Lercher1 / Andrea Griesmacher1 / Gerhard Pölzl2 / Natascha Brinskelle-Schmal3 / Johannes Mair2 / Matthias Frick2 / Gerhard Hawa3

1Central Institute for Medical and Chemical Laboratory Diagnosis, University Hospital Innsbruck, Innsbruck, Austria

2Clinic for Internal Medicine III, Innsbruck Medical University, Austria

3Research and Development, Biomedica Medizinprodukte GmbH & CoKG, Vienna, Austria

Corresponding author: Angelika Hammerer-Lercher, MD, Central Institute of Medical and Chemical Laboratory Diagnostics, LKH-University Hospital of Innsbruck, Anichstraße 35, 6020 Innsbruck, Austria Phone: +43 512 504 82116, Fax: +43 512 504 2488,

Citation Information: Clinical Chemistry and Laboratory Medicine. Volume 47, Issue 10, Pages 1305–1308, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: 10.1515/CCLM.2009.279, October 2009

Keywords: assays; blood donors; heart failure; N-terminal pro B-type natriuretic peptide (NT-proBNP)

Comments (0)

Please log in or register to comment.